Articles by tag: melanoma

CD63-based anti-metastasis drug: truth and risks

Harvard scientists created antibodies to CD63 that stopped melanoma metastasis 100% in mice. We analyze insights, risks, and alternatives. Read more.

FDA Fast Track for dendritic cell therapy dubodencel in melanoma

FDA granted Fast Track status to dubodencel (DOC1021) therapy for the treatment of unresectable melanoma. Learn how personalized dendritic cell vaccine is changing oncoimmunology.